Celltrion Healthcare

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...

South Korean government has set a goal to expand medical service exports by attracting 700,000 foreign patients and receiving 70 applications of ove...

An early-stage startup by young entrepreneurs who developed a digital diagnostic tool for brain disease and an AI-powered business optimization prog...

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...

CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...

South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...

South Korea's KT Corp. next year will launch a medical checkup center in Hanoi, Vietnam, under a strategy to advance its digital healthcare business...

Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...

SINGAPORE - Southeast Asia with a youth population constituting about one-third of the region’s total population and surging internet penetrat...

Defense, healthcare and semiconductor materials companies have been the main investment targets of global funds such as Fidelity and Morgan Stanley ...

South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...

Kakao Healthcare, a digital healthcare platform unit of South Korea's Kakao Group, has teamed up with US digital and health companies such as DexCom...

Nudge Healthcare, a South Korean startup that operates the health management app Cashwalk, has added Italy and Spain to the list of overseas markets...

South Korean small- and medium-sized enterprises (SMEs) expanded their exchange and cooperation with US firms during President Yoon Suk yeol's state...

Healthcare continued to be the preferred sector for South Korean institutional investors this year as it was last year, a survey found. Meanwhile, the...

South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...

Samsung Electronics Co. announced on Tuesday that it will showcase Samsung HealthStack ver. 1.0 at the "2023 HIMSS Global Health Conference & Ex...

Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...

South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...

Nudge Healthcare, a startup that runs the South Korean health management app Cashwork, on Wednesday said it secured its first investment of 30 billi...

South Korea’s LG Electronics Inc. is set to unveil its first digital healthcare product in the second half of this year, three years after it ...

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...

South Korean biosimilar giant Celltrion Group’s founder Seo Jung-jin has returned to management two years after his departure, pledging to mer...

South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...